COH:ASX
Cochlear Ltd
A$129.00
arrow_downward
-0.39%(-0.50) 1D
Oct 8, 4:10:20 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COH...
Open
A$129.16
High
A$130.96
Low
A$127.83
Mkt. cap
8.44B
Avg. vol.
736.66K
Volume
297.55K
Dividend
2.67%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
57.39
52-wk high
A$296.50
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
Open
A$129.16
High
A$130.96
Low
A$127.83
Mkt. cap
8.44B
Avg. vol.
736.66K
Volume
297.55K
Dividend
2.67%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
57.39
52-wk high
A$296.50
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
News stories
From web sources and news partners
AD HOC NEWS
·
6 hours ago
Cochlear stock gets a Hold call as FY26 risks persist
Simply Wall Street
·
23 hours ago
3 Australian Healthcare Stocks With Earnings Growth Over 22%
Investing.com
·
1 day ago
Lake Street initiates Envoy Medical stock at buy on cochlear device
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitecochlear.com